Kong X, Lin Y, Ouyang C, Chen H, Gao X
Drug Des Devel Ther. 2025; 19:1251-1270.
PMID: 40026336
PMC: 11869757.
DOI: 10.2147/DDDT.S493011.
Reschke R, Enk A, Hassel J
Int J Mol Sci. 2024; 25(12).
PMID: 38928238
PMC: 11203481.
DOI: 10.3390/ijms25126532.
Lykhopiy V, Malviya V, Humblet-Baron S, Schlenner S
Genes Immun. 2023; 24(5):248-262.
PMID: 37741949
PMC: 10575774.
DOI: 10.1038/s41435-023-00221-y.
Abu-Romman A, Scholand K, Pal-Ghosh S, Yu Z, Kelagere Y, Yazdanpanah G
Ocul Surf. 2023; 30:57-72.
PMID: 37516317
PMC: 10812880.
DOI: 10.1016/j.jtos.2023.07.008.
Shimizu K, Ueda S, Kawamura M, Aoshima H, Satoh M, Nakabayashi J
J Immunother Cancer. 2023; 11(7).
PMID: 37400134
PMC: 10577731.
DOI: 10.1136/jitc-2022-006409.
The role of regulatory T cells and follicular T helper cells in HBV infection.
Lin N, Yin W, Miller H, Byazrova M, Herrada A, Benlagha K
Front Immunol. 2023; 14:1169601.
PMID: 37275865
PMC: 10235474.
DOI: 10.3389/fimmu.2023.1169601.
Advanced immunophenotyping: A powerful tool for immune profiling, drug screening, and a personalized treatment approach.
Preglej T, Brinkmann M, Steiner G, Aletaha D, Goschl L, Bonelli M
Front Immunol. 2023; 14:1096096.
PMID: 37033944
PMC: 10080106.
DOI: 10.3389/fimmu.2023.1096096.
Identification and expression analysis of IL-2 receptors in large yellow croaker ().
Mu P, Huo J, Sun M, Chen X, Ao J
Fish Shellfish Immunol Rep. 2022; 2:100008.
PMID: 36420493
PMC: 9680057.
DOI: 10.1016/j.fsirep.2021.100008.
Engineered human cytokine/antibody fusion proteins expand regulatory T cells and confer autoimmune disease protection.
VanDyke D, Iglesias M, Tomala J, Young A, Smith J, Perry J
Cell Rep. 2022; 41(3):111478.
PMID: 36261022
PMC: 9631798.
DOI: 10.1016/j.celrep.2022.111478.
The antitumor effect induced by an IL-2 'no-alpha' mutein depends on changes in the CD8 T lymphocyte/Treg cell balance.
Carmenate T, Montalvo G, Lozada S, Rodriguez Y, Ortiz Y, Diaz C
Front Immunol. 2022; 13:974188.
PMID: 36059465
PMC: 9428827.
DOI: 10.3389/fimmu.2022.974188.
Selective delivery of low-affinity IL-2 to PD-1+ T cells rejuvenates antitumor immunity with reduced toxicity.
Ren Z, Zhang A, Sun Z, Liang Y, Ye J, Qiao J
J Clin Invest. 2022; 132(3).
PMID: 35104810
PMC: 8803347.
DOI: 10.1172/JCI153604.
Research Progress on the Role of Regulatory T Cell in Tumor Microenvironment in the Treatment of Breast Cancer.
Liu J, Wang X, Deng Y, Yu X, Wang H, Li Z
Front Oncol. 2021; 11:766248.
PMID: 34868991
PMC: 8636122.
DOI: 10.3389/fonc.2021.766248.
Agonistic nanobodies and antibodies to human VISTA.
Ma Y, Sparkes A, Romao E, Saha S, Gariepy J
MAbs. 2021; 13(1):2003281.
PMID: 34818120
PMC: 8632329.
DOI: 10.1080/19420862.2021.2003281.
MK-6, a novel not-α IL-2, elicits a potent antitumor activity by improving the effector to regulatory T cell balance.
Kobayashi M, Kojima K, Murayama K, Amano Y, Koyama T, Ogama N
Cancer Sci. 2021; 112(11):4478-4489.
PMID: 34545658
PMC: 8586658.
DOI: 10.1111/cas.15127.
Immunomodulatory effect of standardized C. asiatica extract on a promotion of regulatory T cells in rats.
Tawinwung S, Junsaeng D, Utthiya S, Khemawoot P
BMC Complement Med Ther. 2021; 21(1):220.
PMID: 34479568
PMC: 8418037.
DOI: 10.1186/s12906-021-03394-z.
A Small Protein but with Diverse Roles: A Review of EsxA in Mycobacterium-Host Interaction.
Bao Y, Wang L, Sun J
Cells. 2021; 10(7).
PMID: 34209120
PMC: 8305481.
DOI: 10.3390/cells10071645.
Biocompatible Lipid Polymer Cationic Nanoparticles for Antigen Presentation.
Perez-Betancourt Y, de Carvalho Lins Fernandes Tavora B, Faquim-Mauro E, Carmona-Ribeiro A
Polymers (Basel). 2021; 13(2).
PMID: 33430262
PMC: 7825723.
DOI: 10.3390/polym13020185.
Tumor cell-expressed IL-15Rα drives antagonistic effects on the progression and immune control of gastric cancer and is epigenetically regulated in EBV-positive gastric cancer.
Wei J, Guo C, An X, Miao W, Zhang C, Wang B
Cell Oncol (Dordr). 2020; 43(6):1085-1097.
PMID: 32767257
DOI: 10.1007/s13402-020-00542-4.
Defining the Threshold IL-2 Signal Required for Induction of Selective Treg Cell Responses Using Engineered IL-2 Muteins.
Ghelani A, Bates D, Conner K, Wu M, Lu J, Hu Y
Front Immunol. 2020; 11:1106.
PMID: 32582190
PMC: 7291599.
DOI: 10.3389/fimmu.2020.01106.
Cytokines that target immune killer cells against tumors.
Qiao J, Fu Y
Cell Mol Immunol. 2020; 17(7):722-727.
PMID: 32523115
PMC: 7331613.
DOI: 10.1038/s41423-020-0481-0.
